Unlock instant, AI-driven research and patent intelligence for your innovation.

Antisense oligonucleotides targeting folate receptor alpha, and the use thereof

a technology of antisense oligonucleotides and folate receptors, applied in the field of antisense oligonucleotides, can solve problems such as undesirable, and achieve the effects of suppressing the growth of cancerous cells and inhibiting the expression of fr

Inactive Publication Date: 2006-08-10
JHAVERI MONA +2
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The invention is about using antisense oligonucleotides to treat cancers that over-express a protein called FRα. The antisense oligos are complementary to a specific region of the FRα protein and can be administered alone or with a carrier to patients with cancer. The treatment can be effective in reducing the growth of cancer cells and has been tested in animal models of ovarian cancer. The patent also includes structural derivatives of the antisense oligos and describes the use of ribozymes to target the FRα protein. The technical effect of the invention is to provide a new method for treating cancers that targets a specific protein and has shown promising results in animal models.

Problems solved by technology

Antisense suppression of FRα expression reduced thymidine kinase activity and reduced sensitivity to AZT, yet, another indication that antisense supression of FRα was not desirable as it renderd the anti-cancer drug, AZT, ineffective against the disease.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antisense oligonucleotides targeting folate receptor alpha, and the use thereof
  • Antisense oligonucleotides targeting folate receptor alpha, and the use thereof
  • Antisense oligonucleotides targeting folate receptor alpha, and the use thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0074] Reduction of Newly Synthesized αhFR Protein Levels by αhFR Antisense Oligonucleotides.

[0075] Expression of αhFR is known to be elevated in cancer. In particular, increased αhFR expression is found in 90% of human epithelial ovarian malignancies and is associated with a poor disease prognosis. It is possible that over expression of αhFR confers a growth survival advantage in ovarian cancer cells, since folates are involved in numerous cellular processes, including DNA and RNA synthesis. Knocking out receptor function in αhFR-positive cells may therefore prove to be of clinical value in combating ovarian malignancies. Eight different antisense 21 mer oligonucleotides were designed to target the αhFR open reading frame (FIG. 2A) in an attempt to knock out αhFR expression in folate-deficient KB cells, which express significantly high levels of αhFR. FIG. 2B shows that KB cells incubated with 50 μM of AS-1, AS-2 or AS-6 reduced the levels of newly synthesized a αhFR by (up to app...

example 2

[0076] Decreased Viability of Cells Treated With a αhFR Antisense Oligonucleotides.

[0077] The effect of AS-6 on the viability of cultured KB cells was evaluated (FIG. 3). In a reproducible manner, KB cells incubated with 10 or 50 μM AS-6 showed a 20 and 60% decrease, respectively, in overall protein content, compared to the S-6 control. The decrease in cell viability upon AS-6 treatment correlates well with the decrease in newly synthesized αhFR expression, as determined in FIG. 2B. These observations suggest a requirement of αhFR expression for survival of KB cells.

example 3

[0078]αhFR-Targeted Ribozymes Efficiently Cleave αhFR mRNA Sequences.

[0079] Ribozymes are RNAs which are capable of catalyzing RNA cleavage reactions. The hammerhead ribozymes has been extensively studied and involves three putative helical systems: a highly conserved structure that is implicated in catalysis and two flanking regions that can be designed to target the cleavage of the mRNA of interest. Although ribozymes share the potential applications with antisense oligonucleotides, they have the added advantage of catalytic activity that theoretically can allow a single molecule to destroy one or more target RNA. As an alternative approach for knocking out αhFR function, two ribozymes were designed targeted to the 5′ region of the αhFR open reading frame (FIG. 4A). FIG. 4B demonstrates efficient cleavage of in vitro synthesized αhFR mRNA sequences by in vitro synthesized αhFR-targeted ribozymes. The correct size cleavage products for Rz 43 / 65 WT (236 and 846 bp) and Rz 187 / 210 W...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
volumeaaaaaaaaaa
pharmaceutical compositionaaaaaaaaaa
Login to View More

Abstract

The invention relates to treatment of cancers and cancerous cells which over-express α folate receptor (FRα) compared to the normal cells of the same tissue. The invention is directed to antisense oligonucleotides which are complimentary to the coding region of FRα, as well as the pharmaceutical compositions made thereof, and the methods of using the same for treatment of cancers, e.g. cancers of ovary, cervix, uterus, and brain.

Description

CLAIM TO PRIORITY [0001] This application is a divisional of application Ser. No. 10 / 093,523 filed Mar. 11, 2002, which claims priority to U.S. Provisional Application No. 60 / 274,249, the entire disclosure of which is incorporated herein by reference.STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY-SPONSORED RESEARCH AND DEVELOPMENT [0002] The present invention was made with government support. Accordingly, the United States government has certain rights in the invention.BACKGROUND OF THE INVENTION [0003] 1. Field of the Invention [0004] The invention is in the field of medicinal chemistry. In particular, the invention relates to certain antisense oligonucleotides and the use thereof for the treatment of cancer. [0005] 2. Background of the Related Art [0006] Folate vitamins are essential components of intracellular metabolic pathways that transfer single carbon groups during nucleic acid and amino acid synthesis. In particular, folate is essential for de novo synthesis of d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K48/00A61K33/06C07H21/04A61K38/00C12N15/113
CPCA61K38/00C12N15/1138C12N2310/111C12N2310/12C12N2310/121C12N2310/315
Inventor JHAVERI, MONAELWOOD, PATRICKCHUNG, KOONG-NAH
Owner JHAVERI MONA